|
Disclaimer: This list is not inclusive of all medications used in HIV and AIDS therapies and is not intended for use in making clinical decisions. Contact a physician for the right medications for you.
Click on the links below to learn more about each medication.
| BRAND |
GENERIC |
CLASS |
COST |
| Agenerase |
Amprenavir |
HIV protease inhibitor (PI) |
$7,994/yr., $666/month |
 |
|
| Crixivan |
Indinavir |
HIV protease inhibitor (PI) |
$6,280/yr., $523/month |
 |
|
| Fortovase |
Saquinavir |
HIV protease inhibitor (PI) |
$8,011/yr., $668/month |
 |
|
| Kaletra |
Lopinavir/ritonavir |
HIV protease inhibitor (PI) |
$8,125/yr., $677/month |
 |
|
| Norvir |
Ritonavir |
HIV protease inhibitor (PI) |
$8,910/yr., $743/month |
 |
|
| Viracept |
Nelfinavir |
HIV protease inhibitor (PI) |
$8,381/yr., $698/month |
 |
|
| Combivir |
Combivir |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$7,440/yr., $620/month |
 |
|
| Epivir |
Lamivudine, 3TC |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$3,435/yr., $286/month |
 |
|
| Hivid |
Zalcitabine, ddc |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$2,808/yr., $234/month |
 |
|
| Retrovir |
Zidovudine, AZT |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$4,013/yr., $334/month |
 |
|
| Trizivir |
Trizivir |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$12,060/yr., $1,005/month |
 |
|
| Videx & Videx EC |
Didanosine, ddl |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$3,420/yr., $285/month |
 |
|
| Zerit |
Stavudine, d4t |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$3,960/yr., $330/month |
 |
|
| Ziagen |
Abacavir sulfate |
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke) |
$4,615/yr., $384/month |
 |
|
| Viread |
Tenofovir disoproxil fumarate |
Nucleotide analog (also called nucleotide reverse transcriptase inhibitor, NRTI or nuke) |
$4,896/yr., $408/month |
 |
|
| Rescriptor |
Delavirdine |
Non-nucleoside analog (also called non-nucleoside reverse transcriptase inhibitor, NRTI or non-nuke) |
$3,504/yr., $292/month |
 |
|
| Sustiva |
Efavirenz |
Non-nucleoside analog (also called non-nucleoside reverse transcriptase inhibitor, NRTI or non-nuke) |
$4,730/yr., $394/month |
 |
|
| Viramune |
Nevirapine |
Non-nucleoside analog (also called non-nucleoside reverse transcriptase inhibitor, NRTI or non-nuke) |
$3,826/yr., $319/month |
 |
|
| Not yet established |
T-20, Pentafuside |
Experimental fusion inhibitor |
Not yet established because of experimental drug status |
 |
|
| Not yet established |
Tipranavir |
Experimental protease inhibitor |
Not yet established because of experimental drug status |
|
|
 |
|
